We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+11.65%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$864B
AUM Growth
+$69.1B
Cap. Flow
-$8.04B
Cap. Flow %
-0.93%
Top 10 Hldgs %
26.18%
Holding
2,679
New
185
Increased
873
Reduced
1,330
Closed
90

Top Buys

Rank Stock Value
1
MTCH icon
Match Group
MTCH
+$3.17B
2
NKE icon
Nike
NKE
+$1.94B
3
BAC icon
Bank of America
BAC
+$1.84B
4
FDX icon
FedEx
FDX
+$1.78B
5
PNC icon
PNC Financial Services
PNC
+$1.61B

Top Sells

Rank Stock Value
1
PPLI
People Inc
PPLI
+$4.1B
2
FTV icon
Fortive
FTV
+$2.54B
3
LIN icon
Linde
LIN
+$1.53B
4
BABA icon
Alibaba
BABA
+$1.35B
5
WTW icon
Willis Towers Watson
WTW
+$1.13B

Sector Composition

Rank Sector Weight
1 Technology 25.99%
2 Healthcare 16.87%
3 Consumer Discretionary 15.81%
4 Financials 11.47%
5 Communication Services 10.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMHI icon
1326
SEACOR Marine Holdings
SMHI
$264M
$8.43M ﹤0.01%
4,150,867
-1,240
-0% -$3.1K
PS
1327
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$8.42M ﹤0.01%
491,342
+379,682
+340% +$7.27M
PANA.U
1328
DELISTED
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
$8.4M ﹤0.01%
+700,000
New +$8.06M
CEF icon
1329
Sprott Physical Gold and Silver Trust
CEF
$8.17B
$8.4M ﹤0.01%
457,778
-439,862
-49% -$8.44M
NCLH icon
1330
Norwegian Cruise Line
NCLH
$8.98B
$8.35M ﹤0.01%
488,241
+23,708
+5% +$375K
EVOP
1331
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$8.34M ﹤0.01%
335,441
-1,395,784
-81% -$35.1M
RGNX icon
1332
Regenxbio
RGNX
$704M
$8.2M ﹤0.01%
298,016
-18,332
-6% -$598K
DXC icon
1333
DXC Technology
DXC
$1.79B
$8.15M ﹤0.01%
456,473
-33,503
-7% -$611K
ARMK icon
1334
Aramark
ARMK
$16.1B
$8.1M ﹤0.01%
424,199
-225,136
-35% -$4.01M
FNF icon
1335
Fidelity National Financial
FNF
$12.8B
$8.09M ﹤0.01%
268,665
-3,072
-1% -$96.2K
TBPH icon
1336
Theravance Biopharma
TBPH
$878M
$8.05M ﹤0.01%
544,380
+19,919
+4% +$373K
ITCI
1337
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$8.04M ﹤0.01%
313,346
-648,403
-67% -$14.8M
TRHC
1338
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$7.94M ﹤0.01%
194,745
-364,219
-65% -$18.1M
MGP
1339
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$7.92M ﹤0.01%
283,037
+300
+0.1% +$8.34K
CRDF icon
1340
Cardiff Oncology
CRDF
$76.6M
$7.85M ﹤0.01%
+553,359
New +$3.65M
PBCT
1341
DELISTED
People's United Financial Inc
PBCT
$7.82M ﹤0.01%
758,191
-56,153
-7% -$610K
PVH icon
1342
PVH
PVH
$3.76B
$7.79M ﹤0.01%
130,687
-9,709
-7% -$534K
ARYBU
1343
DELISTED
ARYA Sciences Acquisition Corp II Unit
ARYBU
$7.73M ﹤0.01%
+702,800
New +$7.97M
NTNX icon
1344
Nutanix
NTNX
$18.4B
$7.69M ﹤0.01%
346,821
+292,720
+541% +$6.69M
Z icon
1345
Zillow
Z
$8.08B
$7.62M ﹤0.01%
74,990
+25
+0% +$1.95K
NBL
1346
DELISTED
Noble Energy, Inc.
NBL
$7.55M ﹤0.01%
882,771
-43,040
-5% -$421K
TARA icon
1347
Protara Therapeutics
TARA
$233M
$7.54M ﹤0.01%
+448,093
New +$10.4M
WSC icon
1348
WillScot Mobile Mini Holdings
WSC
$4.17B
$7.44M ﹤0.01%
+446,301
New +$7.13M
ACGL icon
1349
Arch Capital
ACGL
$33.5B
$7.43M ﹤0.01%
254,095
-6,551
-3% -$200K
RBA icon
1350
RB Global
RBA
$16B
$7.38M ﹤0.01%
124,508
-35,400
-22% -$1.87M

Similar funds

T. Rowe Price Associates's Q3 2020 Portfolio in Review

As of Q3 2020, T. Rowe Price Associates held 2,679 positions worth $864B, up 8.7% from $795B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q3 2020 filing shows 185 new, 873 increased, 1,330 reduced and 90 closed positions. Its largest new stake was nCino: 5,133,240 shares worth $395M. The largest sale was People Inc, an estimated $4.1B.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q3 2020 buy was nCino: 5,133,240 shares worth $395M.
  • T. Rowe Price Associates added most to Match Group in Q3 2020, an estimated $3.17B increase.
  • T. Rowe Price Associates's biggest Q3 2020 reduction was People Inc, cutting an estimated $4.1B.
  • T. Rowe Price Associates fully exited 58.com Inc in Q3 2020, selling an estimated $468M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $864B portfolio in Q3 2020.
  • T. Rowe Price Associates opened 185 new positions and closed 90 in Q3 2020.
  • T. Rowe Price Associates's portfolio value rose 8.7% quarter-over-quarter to $864B.

Based on T. Rowe Price Associates's 13F filing for Q3 2020, filed 16 Nov 2020.